Patent · US Active

Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine

US11518742B2 · kind B2 · utility

3Cited by

4References

14Claims

0Family size

Assignee

Beckley Psytech Limited · GB

Inventors

Cosmo FEILDING-MELLEN · North Hinksey, GB
Timothy MASON · North Hinksey, GB

Key dates

Filing date	Apr 27, 2022
Grant date	Dec 6, 2022
Priority date	—
Expiry date	Apr 27, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition comprising a pharmaceutically effective amount of a pharmaceutically acceptable benzoate salt of 5-methoxy-N,N-dimethyltryptamine (5MeODMT).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.